Indications and uses
• For the treatment of acne • Helps prevent development of new acne blemishes
• For the treatment of acne • Helps prevent development of new acne blemishes
Salicylic Acid 2%
Acne treatment
• For the treatment of acne
• Helps prevent development of new acne blemishes
For External Use Only
Do not use if you
• are pregnant
• are a child under 3 years of age
• are allergic to salicylates
When using this product
• skin irritation and dryness is more likely to occur if you use another topical acne medication at the same time. If irritation occurs, only use one topical acne medication at a time.
• Avoid unnecessary sun exposure and use a sunscreen.
• Avoid contact with the eyes, lips and mouth.
• First time users may experience tingling sensation and visible peeling. After frequent usage, tingling and peeling will likely reduce.
Stop use and ask a doctor if
• Irritation becomes severe
If swallowed, get medical help or contact a Poison Control Center right away.
(302) 291-7376
• Cleanse the skin thoroughly before applying this product
• For treatment of acne, wet cotton bud or pad with solution and cover the entire affected area with a thin layer one to three times daily. Suitable for both facial and body acne.
• Because excessive drying of the skin may occur, start with one application daily, then gradually increase to two or three times daily if needed or as directed by a doctor.
• If bothersome dryness or peeling occurs, reduce application to once a day or every other day.
• Complement this with other Skinlycious products to reduce the likelihood of skin dryness.
• For full face exfoliant, wet cotton pad with a solution and apply a thin layer in the evening only over the entire face. No need to rinse off. Once skin condition improves, reduce frequency to no more than 3-5 times a week in the evening only.
Water, Alcohol Denat. Mandelic Acid, Glycerin, Purslane, Butylene Glycol, Phenoxyethanol, Ethylhexylglycerin.
• Store in a cool dry place away from direct sun.
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 81574-001-01 | Skinlycious Glow Exfoliant | 28 mL in 1 BOTTLE, GLASS | LIQUID | 28 | 4 | |
| 81574-001-02 | Skinlycious Glow Exfoliant | 5 mL in 1 BOTTLE, GLASS | LIQUID | 5 | 4 | |
| 81574-001-03 | Skinlycious Glow Exfoliant | 8 mL in 1 BOTTLE, GLASS | LIQUID | 8 | 4 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 81574-001 | 81574-001-01, 81574-001-02, 81574-001-03 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| WATER | 059QF0KO0R | IACT |
| ALCOHOL | 3K9958V90M | IACT |
| MANDELIC ACID | NH496X0UJX | IACT |
| GLYCERIN | PDC6A3C0OX | IACT |
| PURSLANE | M6S840WXG5 | IACT |
| BUTYLENE GLYCOL | 3XUS85K0RA | IACT |
| PHENOXYETHANOL | HIE492ZZ3T | IACT |
| ETHYLHEXYLGLYCERIN | 147D247K3P | IACT |
| SALICYLIC ACID | O414PZ4LPZ | ACTIB |
| Version | Effective date | Source | Hydrated |
|---|---|---|---|
| 3 | 2024-10-08 | full-release | 2026-06-01 00:41:35 |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| skinlycious Clear skin complete starter kit | SALICYLIC ACID | Skinlycious Pte Ltd | ab1609b7-a10b-44f3-ab86-a615967b2a57 | 2025-10-03 | Warnings | 81574-001-03 81574000103 |
| Skinlycious Clear Skin Essentials Starter kit | SALICYLIC ACID | Skinlycious Pte Ltd | af2d8318-cbff-4317-adb7-828a92af7868 | 2025-10-03 | Warnings | 81574-001-03 81574000103 |
| Skinlycious Glow Exfoliant | SALICYLIC ACID | Skinlycious Pte Ltd | 4baa8342-e983-43bb-9864-caf14bff21e3 | 2025-10-03 | Warnings | 81574-001-02 81574-001-01 81574-001-03 81574-001 81574000101 81574000102 81574000103 4046b451-de3c-fc19-e063-6294a90a99bd 4baa8342-e983-43bb-9864-caf14bff21e3 |
Adverse event summaries are temporarily unavailable. Other product information remains available.